脓毒症患者新发心房颤动的研究现状及进展  

Research Status and Progress of New Atrial Fibrillation in Patients with Sepsis

作　　者：杜海娜 刘宇鹏[2] 单泓达 

机构地区：[1]承德医学院研究生学院,河北 承德 [2]秦皇岛市第一医院急诊科,河北 秦皇岛

出　　处：《临床医学进展》2025年第1期1226-1231,共6页Advances in Clinical Medicine

摘　　要：心房颤动是脓毒症患者病程中最常见的新发心律失常,脓毒症患者并发心房颤动时治疗更复杂,预后更差,不仅延长住院时间,还会增加患者卒中和死亡的风险。本综述旨在总结分析当前关于脓毒症相关新发心房颤动的研究状况与最新进展,探讨脓毒症患者新发心房颤动的生理机制、风险因素、抗凝治疗及临床结局,以期更全面地理解如何预防心房颤动对脓毒症患者造成的不良影响,并寻求更好的临床治疗决策。Atrial fibrillation is the most common new-onset arrhythmia in patients with sepsis, and patients with sepsis complicated by atrial fibrillation are more complicated to treat, have a worse prognosis, prolong hospital stays, and increase the risk of stroke and death. The purpose of this review is to summarize and analyze the current research status and latest progress on sepsis-related new-onset atrial fibrillation, and to explore the physiological mechanism, risk factors, anticoagulation therapy and clinical outcomes of new-onset atrial fibrillation in patients with sepsis, in order to understand more comprehensively how to prevent the adverse effects of atrial fibrillation on patients with sepsis, and to seek better clinical treatment decisions.

关 键 词：脓毒症 心房颤动 卒中 抗凝治疗 

分 类 号：R54[医药卫生—心血管疾病]